Ingersoll Rand IR has outperformed the market over the past 5 years by 7.23% on an annualized basis producing an average annual return of 19.58%. Currently, Ingersoll Rand has a market capitalization ...

Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage biopharmaceutical company developing innovative treatments that exploit specific cancer cell vulnerabilities while ...

In a report released today, Joseph C Giordano from TD Cowen maintained a Buy rating on IDEX (IEX – Research Report), with a price target of ...

Hedera (HBAR) and Solana (SOL) are struggling, with Solana's price facing resistance and HBAR showing weakness. Meanwhile, ...

IPO - Read IPO Review and Analysis on The Economic Times. Find out IPO Issue Price, Subscription Dates and Status, IPO Listing Date and more.